| EPC139 | Phylodynamic structure of the Botswana HIV epidemic | E-poster | Advances in public health surveillance and new approaches |
| PESUD49 | Photovoicing social ecological resilience and resources for youths living with HIV/AIDS in Western Uganda: towards empowering representations | Poster exhibition | Adaptation to living with HIV for individuals, families and communities |
| EPD037 | Photovoice with key populations and people living with HIV: acceptability and feasibility of online, asynchronous data collection | E-poster | Qualitative and ethnographic methods in HIV research |
| OALBB0102 | Phase I/II study of monoclonal antibody VRC01 with early antiretroviral therapy to promote clearance of HIV-1 infected cells in infants (IMPAACT 2008) | Oral abstract session with live Q&A | Cure strategies in paediatric and adolescent populations |
| EPLBC05 | Phase 3B, randomized, open-label, safety study of dapivirine vaginal ring and oral emtricitabine 200mg/tenofovir disoproxil fumarate 300 mg tablet in breastfeeding mother-infant pairs | E-poster | Other new HIV prevention tools |
| EPB129 | Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Rio de Janeiro, Brazil | E-poster | Polypharmacy |
| OAA0102 | Pharmacological enhancement of IL-15 signaling to improve 'shock-and-kill' strategies against latent HIV | Oral abstract session with live Q&A | Strategies to reduce/eliminate viral reservoirs |
| PEMOA28 | Pharmacologic intervention to reduce chronic inflammation in people with HIV | Poster exhibition | Immunotherapy (including broadly neutralizing antibodies) |
| PESUB22 | Pharmacokinetics of a simplified subcutaneous lenacapavir regimen versus Phase 2/3 regimen | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB176 | Pharmacokinetics (PK) and tolerability of cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) intramuscular (IM) injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |